Plozalizumab (Anti-CCR2 / CD192)

Synonyms: MLN-1202

Plozalizumab (Anti-CCR2 / CD192) is a specific humanized monoclonal antibody targeting CCR2. Plozalizumab can be used for malignant melanoma research. MW:145.5 KD.

Plozalizumab (Anti-CCR2 / CD192)

Click to purchase the isotype control of Plozalizumab (Anti-CCR2 / CD192)

Purity & Quality Control

Batch: A256901 Purity: 99% Protein concentration: 4.13mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective CCR Inhibitors

Name Citation CCR
Adaptavir (DAPTA) 3
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Plozalizumab (Anti-CCR2 / CD192) is a specific humanized monoclonal antibody targeting CCR2. Plozalizumab can be used for malignant melanoma research. MW:145.5 KD.

Product Details

CAS No. 1610761-46-0
Molecular Weight 150 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Plozalizumab (Anti-CCR2 / CD192) | Plozalizumab (Anti-CCR2 / CD192) supplier | purchase Plozalizumab (Anti-CCR2 / CD192) | Plozalizumab (Anti-CCR2 / CD192) cost | Plozalizumab (Anti-CCR2 / CD192) manufacturer | order Plozalizumab (Anti-CCR2 / CD192) | Plozalizumab (Anti-CCR2 / CD192) distributor